186 related articles for article (PubMed ID: 21655045)
1. Intravenously administered anti-recoverin antibody alone does not pass through the blood-retinal barrier.
Kim JH; Kim JH; Kim DH; Park WY; Kim KW; Yu YS
Korean J Ophthalmol; 2011 Jun; 25(3):189-95. PubMed ID: 21655045
[TBL] [Abstract][Full Text] [Related]
2. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity.
Kim JH; Kim JH; Kim KW; Kim MH; Yu YS
Nanotechnology; 2009 Dec; 20(50):505101. PubMed ID: 19923650
[TBL] [Abstract][Full Text] [Related]
3. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
4. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
6. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
7. N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.
Tawfik A; Mohamed R; Kira D; Alhusban S; Al-Shabrawey M
J Mol Med (Berl); 2021 Jan; 99(1):119-130. PubMed ID: 33159240
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
9. Two mouse models for recoverin-associated autoimmune retinopathy.
Lu Y; He S; Jia L; Khan NW; Heckenlively JR
Mol Vis; 2010 Oct; 16():1936-48. PubMed ID: 21031137
[TBL] [Abstract][Full Text] [Related]
10. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
11. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL-1beta) in the lens and mice undergoing retinal degeneration.
Vinores SA; Xiao WH; Zimmerman R; Whitcup SM; Wawrousek EF
Histol Histopathol; 2003 Jul; 18(3):797-810. PubMed ID: 12792892
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
14. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
15. Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction.
Coburn PS; Wiskur BJ; Miller FC; LaGrow AL; Astley RA; Elliott MH; Callegan MC
PLoS One; 2016; 11(5):e0154560. PubMed ID: 27195776
[TBL] [Abstract][Full Text] [Related]
16. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells.
Adamus G; Webb S; Shiraga S; Duvoisin RM
J Autoimmun; 2006 Mar; 26(2):146-53. PubMed ID: 16426815
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
18. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
[TBL] [Abstract][Full Text] [Related]
19. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
